2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Presenter: Craig Beavers

REGISTER for free or LOG IN to view this content

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Up Next

More slides +

We Recommend